New research exposes hidden vulnerability in novel Coronavirus

By Nikita Chaurasia  Date: 2020-08-12

New research exposes hidden vulnerability in novel Coronavirus

The research led by Monica Olvera de la Cruz, Lawyer Taylor Professor of Materials Science and Engineering, and Baofu Qiao, a research assistant professor at the Northwestern University, have reportedly discovered a new vulnerability in the SARS-CoV-2 spike protein, indicating a relatively simple treatment route.

For those unfamiliar, the binding site present in the spike protein on attaching to host cells allows the virus to enter and multiply inside the body. Researchers were able to discover polybasic cleavage site, a positively charged site situated 10 nanometers from the actual binding site.

This positively charged site reportedly enables a strong bond between the spike protein and negatively charged human-cell receptors. Upon this discovery, the researchers devised a way to prevent the virus from bonding to the host cell by designing a negatively charged molecule that could bind with the positively charged cleavage site, cite credible sources.

Olvera de la Cruz claimed that the blocking the cleavage site could be a preventive treatment to reduce the virus’ capability of infecting human cells. The research shows that mutations of the SARS-CoV-2 spike protein impacted the transmission of the virus, she emphasized.  

The research was backed by the U.S. Department of Energy, Northwestern University’s Center for Computation and Theory of Soft Materials, and the Sherman Fairchild Foundation, claim sources.

With this new-found data, the researchers are eyeing to collaborate with Northwestern pharmacologists and chemists to develop a drug that could bind to the spike protein.

In another major development, Russain Microbiology Research Center Gamaleya have already announced the world’s first coronavirus vaccine.

The quest for finding a vaccine to combat the novel coronavirus, which was declared a pandemic on March 11 by the WHO, may finally reach a conclusion with many possible cures emerging into the scene.  

Sources:

https://news.northwestern.edu/stories/2020/08/research-exposes-new-vulnerability-in-sars-cov-2/

https://www.dnaindia.com/world/report-russia-registers-world-s-first-coronavirus-vaccine-president-putin-s-daughter-vaccinated-2837128/amp

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

TCS, Infosys, Accenture workforce to receive free Covid-19 vaccination

TCS, Infosys, Accenture workforce to receive free Covid-19 vaccination

By Nikita Chaurasia

Information technology giants Infosys, Accenture India, and Tata Consultancy Services will reportedly cover Covid-19 vaccination costs for their employees and their family, who are eligible and opt to receive the jab. This news comes along the heels...

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

By Nikita Chaurasia

Motorola Solutions has announced to have been selected by Helsetjenestens Driftsorganisasjon for Nødnett HF (HDO HF) to offer the Norwegian Health Emergency Service with a new CRS (Command Central Control Room Solution). Confirming the news,&...

Nestle India exploring options to directly sell products to consumers

Nestle India exploring options to directly sell products to consumers

By Nikita Chaurasia

Nestle India Ltd. is reportedly exploring their options of trying their hands at direct selling since consumers are largely turning towards the internet to purchase products ranging from staples to medicines amidst the COVID-19 pandemic. While the n...

Razorpay: New funding en route, meteoric rise in market value expected

Razorpay: New funding en route, meteoric rise in market value expected

By Nikita Chaurasia

Indian startup Razorpay is reportedly in discussions with Singapore-based sovereign wealth fund GIC Pvt. Ltd. and other existing investors to raise around USD 200 million in a funding round that would allow the fintech company to double its valuation...

FDA to allow pharma companies modify COVID-19 shots amid variants surge

FDA to allow pharma companies modify COVID-19 shots amid variants surge

By Nikita Chaurasia

With the rising cases of Coronavirus variants, the United States Food & Drug Administration (FDA) has reportedly introduced guidelines for pharmaceutical companies to modify their COVID-19 vaccine doses in an effort to curb the spread of the dise...